P-GLYCOPROTEIN IN HUMAN SARCOMA - EVIDENCE FOR MULTIDRUG RESISTANCE

被引：282
|
作者：
GERLACH, JH
BELL, DR
KARAKOUSIS, C
SLOCUM, HK
KARTNER, N
RUSTUM, YM
LING, V
BAKER, RM
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GRACE CANC DRUG CTR,DEPT EXPTL THERAPEUT,666 ELM ST,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GRACE CANC DRUG CTR,DEPT SURG ONCOL,BUFFALO,NY 14263
[3] PRINCESS MARGARET HOSP,ONTARIO CANC INST,TORONTO M4X 1K9,ONTARIO,CANADA
[4] UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 09期
关键词：
D O I：
10.1200/JCO.1987.5.9.1452
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1452 / 1460
页数：9
相关论文
共 50 条
  • [21] MULTIDRUG RESISTANCE GENES, P-GLYCOPROTEIN AND THE LIVER
    ARIAS, IM
    HEPATOLOGY, 1990, 12 (01) : 159 - 165
  • [22] P-glycoprotein and membrane roles in multidrug resistance
    Ferreira, Ricardo J.
    dos Santos, Daniel J. V. A.
    Ferreira, Maria-Jose U.
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (07) : 929 - 946
  • [23] Multidrug Resistance Through the Spectacle of P-Glycoprotein
    Goda, Katalin
    Bacso, Zsolt
    Szabo, Gabor
    CURRENT CANCER DRUG TARGETS, 2009, 9 (03) : 281 - 297
  • [24] Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein
    Loo, Tip W.
    Bartlett, M. Claire
    Clarke, David M.
    MOLECULAR PHARMACEUTICS, 2004, 1 (06) : 426 - 433
  • [25] Nonylphenol ethoxylates, but not nonylphenol, are substrates of the human multidrug resistance P-glycoprotein
    Loo, TW
    Clarke, DM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) : 478 - 480
  • [26] Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo
    Suto, R
    Abe, Y
    Nakamura, M
    Ohnishi, Y
    Yoshimura, M
    Lee, YH
    Imanishi, T
    Yamazaki, H
    Kijima, H
    Tokunaga, T
    Oshika, Y
    Hiraoka, N
    Tamaoki, N
    Fukuda, H
    Ueyama, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (02) : 287 - 291
  • [27] Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers
    Abbaszadegan, MR
    Cress, AE
    Futscher, BW
    Bellamy, WT
    Dalton, WS
    CANCER RESEARCH, 1996, 56 (23) : 5435 - 5442
  • [28] Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein
    Ballinger, JR
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (01) : 1 - 7
  • [29] Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma
    Coley, HM
    Verrill, MW
    Gregson, SE
    Odell, DE
    Fisher, C
    Judson, IR
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (07) : 881 - 888
  • [30] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN
    CALLAGHAN, R
    HIGGINS, CF
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 294 - 299
12345